GGrantIndex
← Leaderboards

Daniel Kalman

Emory University

$11,539,324
Attributed
$18,006,555
Total exposure
13
Grants
10
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $3.3M · FY200525
$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$18,006,555 · 13

By mechanism

R01$6,211,842 · 3
UH3$4,733,613 · 1
RF1$3,251,767 · 1
R56$1,562,579 · 3
UH2$1,199,999 · 1
R21$729,700 · 2

Top collaborators

Most similar at Emory University

Same institution · by research overlap

Others in their field

Top investigators on “Pathogen

Research focus

PathogenCellsInfectionMediatingAnimalsCaenorhabditis ElegansResearch StudyBaseMutantMutationResponseImmuneImmune ResponseProteinsProtein Tyrosine KinaseBacteriaNematodaGenesResistancePathway InteractionsPharmaceutical PreparationsPublishingCell TypeIn Vivo

Grant awards (35)

Indoles from commensal microbiota promote mobility during aging$3,251,767
RF1 · FY2025 · AG · contact PI
Indoles from commensal microbiota promote mobility during aging$387,006
R56 · FY2024 · AG · contact PI
Microbiota-derived indoles control epithelial barrier integrity in response to acute stressors and aging$395,272
R56 · FY2020 · DK · contact PI
Development of Gleevec for TB and TB/HIV$1,571,205
UH3 · FY2019 · AI · contact PI
Development of Gleevec for TB and TB/HIV$1,534,659
UH3 · FY2018 · AI · contact PI
Bacterial factors modulating host immunity$351,000
R01 · FY2018 · DK · contact PI
Intestinal microbiota effects on damage tolerance in aging$195,000
R21 · FY2018 · AG · contact PI
Development of Gleevec for TB and TB/HIV$1,627,749
UH3 · FY2017 · AI · contact PI
Bacterial factors modulating host immunity$351,000
R01 · FY2017 · DK · contact PI
Intestinal microbiota effects on damage tolerance in aging$234,000
R21 · FY2017 · AG · contact PI
Development of Gleevec for TB and TB/HIV$599,999
UH2 · FY2016 · AI · contact PI
Bacterial factors modulating host immunity$351,000
R01 · FY2016 · DK · contact PI
Development of Gleevec for TB and TB/HIV$600,000
UH2 · FY2015 · AI · contact PI
Bacterial factors modulating host immunity$351,000
R01 · FY2015 · DK · contact PI
Mechanisms of pox virus motility and release$430,216
R01 · FY2012 · AI · contact PI
Mechanisms of pox virus motility and release$430,216
R01 · FY2011 · AI · contact PI
Mechanisms of pox virus motility and release$434,561
R01 · FY2010 · AI · contact PI
A C.elegans model for EPEC and EHEC pathogenesis$289,673
R01 · FY2010 · DK · contact PI
Mechanisms of pox virus motility and release$438,950
R01 · FY2009 · AI · contact PI
A C.elegans model for EPEC and EHEC pathogenesis$296,703
R01 · FY2009 · DK · contact PI
A C.elegans model for EPEC and EHEC pathogenesis$99,984
R01 · FY2009 · DK · contact PI
Mechanisms of pox virus motility and release$446,965
R01 · FY2008 · AI · contact PI
A C.elegans model for EPEC and EHEC pathogenesis$293,446
R01 · FY2008 · DK · contact PI
Role of tyrosine kinases in EPEC and EHEC pathogenesis$326,412
R01 · FY2007 · AI · contact PI
A C. elegans model for EPEC and EHEC pathogenesis$207,988
R56 · FY2007 · DK · contact PI
Role of tyrosine kinases in EPEC and EHEC pathogenesis$460,091
R01 · FY2006 · AI · contact PI
Inhibitors of Pox virus motility and release$358,113
R56 · FY2006 · AI · contact PI
A C. elegans model for EPEC and EHEC pathogenesis$214,200
R56 · FY2006 · DK · contact PI
Role of tyrosine kinases in EPEC and EHEC pathogenesis$344,250
R01 · FY2005 · AI
Role of tyrosine kinases in EPEC and EHEC pathogenesis$344,250
R01 · FY2004 · AI
A C. elegans model for EPEC and EHEC pathogenesis$151,094
R21 · FY2004 · DK
Role of tyrosine kinases in EPEC and EHEC pathogenesis$172,125
R01 · FY2003 · AI
A C. elegans model for EPEC and EHEC pathogenesis$149,606
R21 · FY2003 · DK
Wide-Field Deconvolution Microscopy System$317,055
S10 · FY2002 · RR
Signaling pathways that cause localized morphological changes$0
P30 · FY2001 · AR